MYRX’s MPC-0920 is another oral anticoagulant that has evidently been discontinued; it was similar to Pradaxa insofar as it was a direct thrombin inhibitor (rather than an FXa inhibitor like Eliquis and Xarelto).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”